Home / Conferences / World Biosimilar Congress USA 2017

World Biosimilar Congress USA 2017 Posted 12/08/2016

World Biosimilar Congress USA
23–24 May 2017
Hilton San Diego Resort and Spa 
San Diego, CA, USA

The World Biosimilar Congress USA 2017 is a strategic meeting that brings together global biopharma companies to discuss strategies for bringing biosimilars to the American market. Our 2016 event brought together the largest gathering of biosimilar stakeholders, including PBMs and payers, and drove the conversation forward on the future of biosimilars in the United States. The 2017 edition will offer an expanded agenda, featuring two dedicated streams—one for the business and strategic end, and the other for the analytical and manufacturing challenges that still exist on the scientific end. The new analytical stream will allow us to dive deeper into the science of biosimilar development – and all of the challenges that come along with it as more companies start to expand their pipelines and seek US FDA approval.

Register now: http://goo.gl/V4g1Qj

For more information, contact Ms Danielle La Fountain at danielle.lafountain@terrapinn.com or +1 646 619 1835.

Comments (0)

Generics News Research General


Biosimilars News Research General